Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase
暂无分享,去创建一个
G. Schmidt | V. Heinemann | P. Stieber | D. Nagel | P Stieber | D Nagel | V Heinemann | D Di Gioia | G P Schmidt | A Baur-Melnyk | D. Di Gioia | A. Baur‐Melnyk
[1] S. Ciatto,et al. Intensive diagnostic follow-up after treatment of primary breast cancer: A randomised trial , 1993 .
[2] D. Chan,et al. Clinical evaluation of the Elecsys CA 15-3 test in breast cancer patients. , 2003, Clinical laboratory.
[3] S. Heiba,et al. Impact of PET/CT in Comparison With Same Day Contrast Enhanced CT in Breast Cancer Management , 2007, Clinical nuclear medicine.
[4] Ora Israel,et al. The role of FDG‐PET/CT in suspected recurrence of breast cancer , 2006, Cancer.
[5] Sung-Bae Kim,et al. Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. , 2012, The New England journal of medicine.
[6] F L Bookstein,et al. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. , 1985, AJR. American journal of roentgenology.
[7] A Ruibal Morell,et al. CEA serum levels in non-neoplastic disease. , 1992, The International journal of biological markers.
[8] D. Vanel,et al. MRI of bone metastases , 1998, European Radiology.
[9] M. Duffy,et al. Tumor Markers in Breast Cancer – European Group on Tumor Markers Recommendations , 2005, Tumor Biology.
[10] H. Curtin,et al. The New Imaging-Based Classification for Describing the Location of Lymph Nodes in the Neck with Particular Regard to Cervical Lymph Nodes in Relation to Cancer of the Larynx , 2000, ORL.
[11] S. Kumita,et al. FDG-PET/CT in the diagnosis of recurrent breast cancer , 2012, Acta radiologica.
[12] M. Piccart,et al. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. , 2012, The New England journal of medicine.
[13] R. Gelber,et al. Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] E. Imhoff,et al. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer , 2004, European Radiology.
[15] E. Winer,et al. Use and duration of chemotherapy in patients with metastatic breast cancer according to tumor subtype and line of therapy. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.
[16] G M Clark,et al. Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Michael R Hamblin,et al. CA : A Cancer Journal for Clinicians , 2011 .
[18] M. Piccart,et al. Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades? , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[19] A. Nicolini,et al. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients. , 1991, British Journal of Cancer.
[20] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[21] Y. Naito,et al. A mathematical model of axillary lymph node involvement considering lymph node size in patients with breast cancer , 2001, Breast cancer.
[22] G. Gazelle,et al. Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. , 2001, Radiology.
[23] A. Mehrabi,et al. Liver Metastases from Breast Cancer , 2015 .
[24] J. Carreras,et al. Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers. , 2002, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[25] B. Gross,et al. Upper abdominal lymph nodes: criteria for normal size determined with CT. , 1991, Radiology.
[26] H. Takeyama,et al. Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review , 2012, Breast Cancer.
[27] A. Nicolini,et al. "Tumour marker guided" salvage treatment prolongs survival of breast cancer patients: final report of a 7-year study. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[28] H. Iwata. Future treatment strategies for metastatic breast cancer: curable or incurable? , 2012, Breast Cancer.
[29] J. Debatin,et al. Whole-body MR imaging: evaluation of patients for metastases. , 2004, Radiology.
[30] Z. Bago-Horvath,et al. Impact of Her‐2‐Targeted Therapy on Overall Survival in Patients With Her‐2 Positive Metastatic Breast Cancer , 2013, The breast journal.
[31] Seung Ah Lee,et al. Does Liver Resection Provide Long-Term Survival Benefits for Breast Cancer Patients with Liver Metastasis? A Single Hospital Experience , 2014, Yonsei medical journal.
[32] M. Federico,et al. Relative and disease-free survival for breast cancer in relation to subtype: a population-based study , 2013, Journal of Cancer Research and Clinical Oncology.
[33] Martín Velasco,et al. Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients , 2004, Breast Cancer Research and Treatment.
[34] Thomas J. Smith,et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] Hans-Jürgen Gallowitsch,et al. F-18 Fluorodeoxyglucose Positron-Emission Tomography in the Diagnosis of Tumor Recurrence and Metastases in the Follow-Up of Patients With Breast Carcinoma: A Comparison to Conventional Imaging , 2003, Investigative radiology.
[36] R. Santoro,et al. Liver metastases from breast cancer. Results of surgical resection. , 2002, Hepato-gastroenterology.
[37] M. Indelli,et al. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators. , 1994, JAMA.
[38] M. Kanematsu,et al. Spectrum of MRI appearances of untreated metastases of the liver. , 2003, AJR. American journal of roentgenology.
[39] K. Eichler,et al. Breast cancer metastases in liver: laser-induced interstitial thermotherapy--local tumor control rate and survival data. , 2004, Radiology.
[40] Kristine Broglio,et al. Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] M. Mayerhoefer,et al. Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer. , 2010, European journal of radiology.
[42] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[43] R. Wahl,et al. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.
[44] R. Molina,et al. C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients. , 1999, Anticancer research.
[45] R. D. Hunter,et al. WHO Handbook for Reporting Results of Cancer Treatment , 1980 .
[46] W. Oyen,et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[47] S. Ciatto,et al. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. , 1994, JAMA.
[48] E. Winer,et al. International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured? , 2010, Journal of the National Cancer Institute.
[49] R. Rouzier,et al. Breast cancer with synchronous metastases: trends in survival during a 14-year period. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50] D. Dodwell,et al. The oligometastatic state in breast cancer: hypothesis or reality. , 2005, Breast.
[51] Y Wang,et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[52] M. Palmer,et al. WHO Handbook for Reporting Results of Cancer Treatment , 1982, British Journal of Cancer.
[53] Karen Gelmon,et al. Metastatic behavior of breast cancer subtypes. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.